A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Zeng, Zheng ^a   Guan, Li ^b   An, Ping ^b   Sun, Shan ^c   O'Brien, Stephen J ^d   Winkler, Cheryl A ^b   Yu, Yanyan ^a   Xu, Xiaoyuan ^a   Lu, Haiying ^a   Hu, Darong ^e   Wang, Rongbing ^f   Chen, Yifan ^f   Hao, Cunyi ^g   Zhou, Heping ^h   Han, Zhonghou ⁱ   Bao, Lidao ^j   Zhang, Xiping ^j   Guo, Dasi ^k   Zhang, Yaoxin ^l   Dou, Xiaoguang ^m   Wei, Lai ⁿ   Rui, Jingan ^o   Qu, Qiang ^o   more..

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b SAIC FREDERICK INC   (United States)

^c Conservation International ^*  (China)

^d NATIONAL CANCER INSTITUTE   (United States)

^e CHINESE PLA GENERAL HOSPITAL   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g Beijing Institute of Tumor Prevention and Therapy   (China)

^h SHANXI MEDICAL UNIVERSITY   (China)

ⁱ No1 Hospital of Qinhuangdao   (China)

^j INNER MONGOLIA MEDICAL COLLEGE   (China)

^k Department of Infectious Diseases   (China)

^l XINJIANG MEDICAL UNIVERSITY   (China)

^m CHINA MEDICAL UNIVERSITY   (China)

ⁿ PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^o PEKING UNION MEDICAL COLLEGE   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CHINA; CLINICAL PROTOCOL; CONTROLLED STUDY; DIETARY INTAKE; DNA EXTRACTION; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HEPATITIS B; HEREDITY; HOST SUSCEPTIBILITY; HUMAN; IMMUNOPATHOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PROTEIN PROTEIN INTERACTION; QUESTIONNAIRE; VIRUS CARRIER; VIRUS REPLICATION; ASIAN; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; HOST PATHOGEN INTERACTION; LIVER FUNCTION TEST; METHODOLOGY; MULTICENTER STUDY; RISK FACTOR; VIROLOGY;

HEPATITIS ANTIBODY; HEPATITIS B ANTIGEN;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; CASE-CONTROL STUDIES; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RESEARCH DESIGN; RISK FACTORS;

EID: 39049130196     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-1     Document Type: Article

References (56)

1. Atkinson W Wolfe C Humiston S Nelson R (Eds) Epidemiology and Prevention of Vaccine-Preventable Diseases Atlanta, GA: Public Health Foundation, Centers for Disease Control and Prevention sixth 2000.
2. World Health Organization Hepatitis B http://www.who.int/csr/disease/ hepatitis/whocdscsrlyo20022/en/
3. Boni C Penna A Ogg GS Bertoletti A Pilli M Cavallo C Cavalli A Urbani S Boehme R Panebianco R Fiaccadori F Ferrari C Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy Hepatology 2001, 33:963-971. 10.1053/ jhep.2001.23045 11283861
4. Ohkubo K Kato Y Ichikawa T Kajiya Y Takeda Y Higashi S Hamasaki K Nakao K Nakata K Eguchi K Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma Cancer 2002, 94:2663-2668. 10.1002/cncr.10557 12173334
5. Yu MW Yeh SH Chen PJ Liaw YF Lin CL Liu CJ Shih WL Kao JH Chen DS Chen CJ Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men J Natl Cancer Inst 2005, 97:265-272. 15713961
6. Liaw YF Sung JJY Chow WC Geoffrey F Lee CZ Yuen H Tanwandee T Tao QM Shue K Keene ON Dixon JS Gray DF Sabbat J Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 2004, 351:1521-1531. 10.1056/NEJMoa033364 15470215
7. Lin SM Sheen IS Chien RN Chu CM Liaw YF Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection Hepatology 1999, 29:971-975. 10.1002/hep.510290312 10051505
8. Van Zonneveld M Honkoop P Hansen BE Niesters HGM Murad SD de Man RA Schalm SW Janssen HLA Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B Hepatology 2004, 39:804-810. 10.1002/hep.20128 14999700
9. Mayerat C Mantegani A Frei PC Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 1999, 6:299-304. 10.1046/j.1365-2893.1999.00174.x 10607244
10. Kao JH Chen PJ Lai MY Chen DS Hepatitis B genotypes and correlated with clinical outcomes in patients with chronic hepatitis B Gastroenterology 2000, 118:554-559. 10.1016/S0016-5085(00)70261-7 10702206
11. Ding X Mizokami M Yao G Xu B Orito E Ueda R Nakanishi M Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China Intervirology 2001, 44:43-47. 10.1159/000050029 11223719
12. Orito E Mizokami M Sakugawa H Michitaka K Ishikawa K Ichida T Okanoue T Yotsuyanagi H Iino S A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group Hepatology 2001, 33:218-223. 10.1053/ jhep.2001.20532 11124839
13. Carman WF Zanetti AR Karayiannis P Waters J Manzillo G Tanzi E Zuckerman AJ Thomas HC Vaccine-induced escape mutant of hepatitis B virus Lancet 1990, 336:325-329. 10.1016/0140-6736(90)91874-A 1697396
14. Howard CR The structure of hepatitis B envelope and molecular variants of hepatitis B virus J Viral Hepat 1995, 2:165-170. 10.1111/ j.1365-2893.1995.tb00024.x 7489342
15. Liang TJ Hasegawa K Rimon N Wands J Ben-Porath E A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis N Engl J Med 1991, 324:1705-1709. 2034247
16. Sato S Suzuki K Akahane Y Akamatsu K Akiyama K Yunomura K Tsuda F Tanaka T Okamoto H Miyakawa Y Mayumin M Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis Ann Intern Med 1995, 122:241-248. 7825758
17. Kaneko M Uchida T Moriyama M Arakawa Y Shikata T Gotoh K Mima S Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B J Med Virol 1995, 47:204-208. 10.1002/ jmv.1890470304 8551270
18. Moriyama K Okamoto H Tsuda F Mayumi M Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections Virology 1996, 226:269-280. 10.1006/viro.1996.0655 8955047
19. Buckwold V Xu Z Chen M Yen T Ou J Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication J Virol 1996, 70:5845-5851. 190601 8709203
20. Baumert T Liang T Precore mutants revised Hepatology 1996, 23:184-186. 10.1002/hep.510230125 8550040
21. Milich DR Pathobiology of acute and chronic hepatitis B virus infection: an introduction J Viral Hepat 1997, 4 Suppl 2:25-30. 9429207
22. Liang TJ Hasegawa K SJ SJM Shapiro CN Yoffe B McMahon BJ Feng C Bei H Alter MJ Dienstag JL Hepatitis B virus precore mutation and fulminant hepatitis in the United States J Clin Invest 1994, 93:550-555. 293877 8113393
23. Laskus T Persing DH Nowicki MJ Mosley MJ Rakela J Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States Gastroenterology 1993, 105:1173-1178. 8405863
24. Ohnishi K Iida S Iwama S Goto N Nomura F Takashi M Mishima A Kono K Kimura K Musha H Kotota K Okuda K The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: Relation to hepatitis B surface antigen carriage Cancer 1982, 49:672-677. 10.1002/ 1097-0142(19820215)49:4<672::AID-CNCR2820490415>3.0.CO;2-# 6275976
25. Frieden TR Ozick L McCord C Nainan OV Workman S Comer G Lee TP Byun KS Patel D Henning KJ Chronic liver disease in central Harlem: The role of alcohol and viral hepatitis Hepatology 1999, 29:883-888. 10.1002/ hep.510290308 10051493
26. Arico S Galatola G Tabone M Corrao G Torchio P Valenti M De la Pierre M The measure of life-time alcohol consumption in patients with cirrhosis: reproducibility and clinical relevance Liver 1995, 15:202-208. 8544643
27. Sun Z Lu P Gail MH Pee D Zhang Q Ming L Wang J Wu Y Liu G Wu Y Zhu Y Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1 Hepatology 1999, 30:379-383. 10.1002/ hep.510300204 10421643
28. Yeh FS Yu MC Mo CC Luo S Tong MJ Henderson BE Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China Cancer Res 1989, 49:2506-2509. 2539905
29. Wang JS Huang T Su J Liang F Wei Z Liang Y Luo H Kuang SY Qian GS Sun G He X Kensler TW Groopman JD Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China Cancer Epidemiol Biomarkers Prev 2001, 10:143-146. 11219772
30. Ross RK Yuan JM Yu MC Wogan GN Qian GS Tu JT Groopman JD Gao YT Henderson BE Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma Lancet 1992, 339:943-946. 10.1016/0140-6736(92)91528-G 1348796
31. Qian GS Ross RK Yu MC Yuan JM Gao YT Henderson BE Wogan GN Groopman JD A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China Cancer Epidemiol Biomarkers Prev 1994, 3:3-10. 8118382
32. Hsu IC Metcalf RA Sun T Welsh JA Wang NJ Harris CC Mutational hotspot in the p53 gene in human hepatocellular carcinomas Nature 1991, 350:427-428. 10.1038/350427a0 1849234
33. Coursaget P Depril N Chabaud M Nandi R Mayelo V LeCann P Yvonnet B High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal Br J Cancer 1993, 67:1395-1397. 8390289
34. Thursz MR Kwiatkowski D Allsopp CEM Greenwood BM Thomas HC Hill AVS Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia N Engl J Med 1995, 332:1065-1069. 10.1056/ NEJM199504203321604 7898524
35. Hohler T Gerken G Notghi A Lubjuhn R Taheri H Protzer U Lohr HF Schneider PM Meyer zum Buschenfelde KH Rittner C HLA-DRB1*1301 and *1302 protect against chronic hepatitis B J Hepatol 1997, 26:503-507. 10.1016/S0168-8278(97)80414-X 9075656
36. Thio CL Carrington M O'Brien SJ Vlahov D Nelson KE Astemborski JA Thomas DL The association of HLA alleles and clearance of hepatitis B among African Americans J Infect Dis 1999, 179:1004-1006. 10.1086/314684 10068598
37. Almarri A Batchelor JR HLA and hepatitis B infection Lancet 1994, 344:1194-1195. 10.1016/S0140-6736(94)90510-X 7934542
38. Thio CL Thomas DL Karacki P Gao X Marti D Kaslow RA Goedert JJ Hilgartner M Strathdee SA Duggal P O'Brien SJ Astemborski J Carrington M Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection J Virol 2003, 77:12083-12087. 254245 14581545 10.1128/JVI.77.22.12083-12087.2003
39. Hohler T Kruger A Gerken G Schneider PM Meyer zBK Rittner C A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection Clin Exp Immunol 1998, 111:579-582. 1904884 9528902 10.1046/j.1365-2249.1998.00534.x
40. Kim YJ Lee HS Im JP Min BH Kim HD Jeong JB Yoon JH Kim CY Kim MS Kim JY Jung JH Kim LH Park BL Shin HD Association of transforming growth factor-β1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection Exp Mol Med 2003, 35:196-202. 12858019
41. Migita K Miyazoe S Maeda Y Daikoku M Abiru S Ueki T Yano K nagaoka S Matsumoto T Nakao K hamasaki K Yatsuhashi H Ishibashi H Eguchi K Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association with between TGF-β1 polymorphisms and hepatocellular carcinoma J Hepatol 2005, 42:505-510. 10.1016/ j.jhep.2004.11.026 15763337
42. Shin HD Park BL Kim LH Jung JH Kim JY Yoon JH Kim YJ Lee HS Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma Hum Mol Genet 2003, 12:901-906. 10.1093/hmg/ddg104 12668613
43. Tsang LH Lin MT Shau WY Lin WC Chang FY Chien KL Hansen JA Chen DS Chen PJ Correlation of interleukin 10 gene haplotype with hepatocellular carcinoma in Taiwan Tissue Antigen 2006, 67:127-133. 10.1111/ j.1399-0039.2006.00536.x
44. Thomas HC Foster GR Sumiya M McIntosh D Jack DL Turner MW Summerfield JA Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection Lancet 1996, 348:1417-1419. 10.1016/ S0140-6736(96)05409-8 8965590
45. Yuen MF Lau CS Lau YL Wong WM Cheng CC Lai CL Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection Hepatology 1999, 29:1248-1251. 10.1002/ hep.510290417 10094971
46. Hohler T Wunschel M Gerken G Schneider PM Meyer zBK Rittner C No association between mannose-binding lectin alleles and susceptibility to chronic hepatitis B virus infection in German patients Exp Clin Immunogenet 1998, 15:130-133. 10.1159/000019064 9813410
47. Bellamy R Ruwende C McAdam KP Thursz M Sumiya M Summerfield J Gilbert SC Corrah T Kwiatkowski D Whittle HC Hill AV Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans QJM 1998, 91(1):13-18. 10.1093/qjmed/91.1.13 9519208
48. Bellamy R Ruwende C Corrah T McAdam KP Thursz M Whittle HC Hill AV Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene J Infec Dis 1999, 179:721-724. 10.1086/314614
49. Yu MW Cheng SW Lin MW Yang SY Liaw YF Chang HC Hsiao TJ Lin SM Lee SD Chen PJ Liu CJ Chen CJ Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatocellular carcinoma J Natl Cancer Inst 2000, 92:2023-2028. 10.1093/jnci/92.24.2023 11121465
50. Yu MW Yang YC Yang SY Cheng SW Liaw YF Lin SM Chen CJ Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: A nested case-control study among men J Natl Cancer Inst 2001, 93:1644-1651. 11698569
51. Chinese Medical Association of Infectious Diseases and Parasites Chinese Medical Association of Hepatology Protocol of prevention and treatment in viral hepatitis Chinese J Hepatology (Chinese) 2000 6 324-9 http://wanfang.calis.edu.cn/qikan/periodical.articles/zhgzbzz/zhgz2000/ 0006pdf/000601.pdf
52. Williams R Global challenges in liver disease Hepatology 2006, 44:521-524. 10.1002/hep.21347 16941687
53. Campbell CD Ogburn EL Lunetta KL Lyon HN Freedman ML Groop LC Altshuler D Ardlie KG Hirschhorn JN Demonstrating stratification in a European American population Nat Genet 2005, 37:868-872. 10.1038/ng1607 16041375
54. Lander ES Schork NJ Genetic dissection of complex traits Science 1994, 265:2037-2048. 10.1126/science.8091226 8091226
55. Pritchard JK Stephens M Rosenberg NA Donnelly P Association mapping in structured populations Am J Hum Genet 2000, 67:170-181. 1287075 10827107 10.1086/302959
56. Manolio TA Bailey-Wilson JE Collins FS Genes, environment and the value of prospective cohort studies Nature Review Genetics 2006, 7:812-820. 10.1038/nrg1919